Dr. Ryan Merrell

IDH inhibitors are now approved by the Food and Drug Administration (FDA) and are available for patients with lower-grade gliomas, offering a therapeutic option with a more manageable side effect profile compared with traditional chemotherapy, according to Dr. Ryan Merrell. […]